Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 5, 2023
Deals

Sept. 5 Quick Takes: Moulder’s Zenas in regional deal with BMS for bispecific

Plus: Beam moves base editors into the clinic and updates on Star, Tivdak, Olema and Insmed’s Arikayce 
BioCentury | Dec 6, 2022
Data Byte

Pulmocide joins trio of start-ups with venture raises

Entact Bio, Vega mark debuts alongside $52M series C extension for U.K.’s Pulmocide
BioCentury | Sep 19, 2019
Targets & Mechanisms

Regeneron's new take on bispecifics: activating complement

Why Regeneron built a bispecific platform that harnesses the complement system
BioCentury | Feb 13, 2018
Distillery Techniques

Assays and screens

BioCentury | Apr 3, 2008
Targets & Mechanisms

Hitting cancer's sweet spot

BioCentury | Nov 6, 2006
Regulation

Shock therapy

BioCentury | Oct 9, 2006
Politics, Policy & Law

Valid biomarkers

BioCentury | Jan 11, 1999
Clinical News

Corgenix Medical Corp. regulatory update

Items per page:
1 - 10 of 12